Evelo Biosciences rakes in $50 mln Series B
Cambridge, Massachusetts-based Evelo Biosciences, a biotech company, has closed $50 million in Series B financing round. The investors included Flagship Pioneering, GV, Celgene, Mayo Clinic and Alexandria Venture Investments.
11 July 2017•1 min read
